News of the LymPro LP002 data tomorrow will be the final in a string of important catalysts that haven't really moved the stock price very much. If the multivariant data is in the mid to high 80s the stock will remain where it is. If it is in the 90s it may move up some....maybe test .10 cents or go over it a bit.

But the news that will really move the stock won't come until after January 1st. News of pharmas committing to use LymPro in the AD trials will cause the stock to rise to the mid teens in my opinion. News of a more concrete arrangement with ICON where they give us some up front money will cause us to move above .20 cents.

I still believe we'll be above .20 cents by February 1st.

There could also be some surprises no one has talked about that could help us.